Deuterium Capital Management, LLC Kronos Bio, Inc. Transaction History
Deuterium Capital Management, LLC
- $36.1 Million
- Q1 2025
A detailed history of Deuterium Capital Management, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Deuterium Capital Management, LLC holds 146,745 shares of KRON stock, worth $99,786. This represents 0.33% of its overall portfolio holdings.
Number of Shares
146,745Holding current value
$99,786% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding KRON
# of Institutions
49Shares Held
19.4MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.88 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.31 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$985,0840.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$977,9970.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$969,0440.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $38.6M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...